RESULTS
a r t i c l e s Proteasomes are heterogeneous multisubunit catalytic complexes that consist of a core 20S stacked ring of α/β subunits with an α 7 β 7 β 7 α 7 architecture able to associate with 19S regulatory cap particles to form a 26S proteasome 1 . Among the other 20S-containing proteasomes are 20S proteasomes capped with 11S or PA200 (ref. 1) . Whereas capped 26S proteasomes mediate the ATP-dependent degradation of ubiquitinated proteins, uncapped 20S proteasomes do not require ubiquitin or ATP for their catalytic function [2] [3] [4] . Recent studies have shown that 20S proteasomes may have key biological functions separate from the canonical 26S ubiquitin proteasome, particularly in clearing unstructured proteins and in degrading proteins during cellular stress 4 .
20S proteasomes are absolutely essential in mammalian cells. In lieu of genetic perturbation, scientists have used many different inhibitors, such as MG-132, lactacystin, epoxomicin, and peptide boronates 5 , to study proteasome function. Studies involving these inhibitors have revealed diverse roles for the proteasome in many different tissues and contexts, driven by protein homeostasis through ubiquitin-dependent proteasomal degradation. Typically, these processes require proteasome function over hours to days (long-term). Indeed, proteasomes do have such long-term roles in important aspects of neuronal function such as synaptic remodeling and cell migration 6, 7 . However, proteasome function is also required for activitydependent neuronal processes that take place within very short periods (seconds to minutes), such as regulation of the speed and intensity of neuronal transmission, or the maintenance of long-term potentiation, a molecular underpinning of learning and memory 6, [8] [9] [10] [11] [12] [13] . Theoretically, short-term inhibition of the proteasome should not be able to meaningfully change the overall protein landscape, so it has been unclear how proteasomes could rapidly alter neuronal function. Thus, we reasoned that an unidentified function for proteasomes in the nervous system must exist.
Changes in calcium dynamics and transients underlie many of the neuronal processes that occur over short timescales. Indeed, perturbation of proteasome activity has been shown to affect calcium dynamics in neurons 13, 14 . In agreement with these findings, we observed that acute addition of the pan-proteasome inhibitor MG-132 to neurons suppressed neuronal-activity-induced calcium signaling ( Supplementary  Fig. 1) . The observed effect on calcium dynamics occurred within seconds of the MG-132 addition, and thus was indicative of a signaling role for proteasomes that was independent of their proteostatic role. Previous studies that addressed the role of proteasomes in the nervous system either used pan-proteasome inhibitors such as MG-132 or focused on the 26S proteasome through alteration of the ubiquitination pathway 11, 13, 15 . These approaches do not distinguish between uncapped 20S and capped 20S proteasomes. We considered that an evaluation of proteasomes in the nervous system without bias toward 20S or 20S-containing proteasomes would provide a means to identify unique proteasomes that could have acute signaling functions. a r t i c l e s methods involved inherently select for the analysis of larger complexes, and therefore are more likely to identify singly and doubly capped proteasomes. In order to undertake a high-resolution and unbiased evaluation of the localization of all proteasomes (20S and 20S-containing) in the nervous system, we carried out an immunogold electron microscopy (immuno-EM) analysis of hippocampal slice preparations, using antibodies raised against proteasome β2, β5, or α2 subunits, core 20S proteasome subunits common to all catalytically active proteasomes 1, 19 .
We first carried out western blotting of mouse brain lysates to assess the antibodies used for our immuno-EM studies. We lysed brains from mice at postnatal day 30 (P30) and prepared them for SDS-PAGE, and then we subjected the lysates to immunoblotting with antibodies to proteasome β2, β5, and α2 subunits. Each antibody recognized a single band in the western blot at the appropriate molecular weight ( Fig. 1a-e ). We then examined mouse hippocampal sections by immuno-EM with these antibodies and appropriate gold-conjugated secondary antibodies. We did not detect any significant staining with the secondary gold-conjugated antibodies alone (Supplementary Fig. 2a-c) . We observed a diverse subcellular and cytosolic distribution of gold particles that corresponded to proteasome subunits, as previously reported 1 (Fig. 1a-e and Supplementary Fig. 3a-c) . Unexpectedly, we noted that ~40% of all gold particles localized to neuronal plasma membranes (PMs). We obtained similar results when we used two additional antibodies to β2 and β5 subunits, but directed against different epitopes (Fig. 1b,d and Supplementary Fig. 3a,b) . In contrast, we did not observe PM localization of gold particles when we used antibodies to the 19S cap proteins Rpt5 or S2 subunit ( Fig. 1f and Supplementary Fig. 3d ). Immunostaining with these 19S antibodies showed diffuse cytosolic localization, in agreement with prior studies 10 .
We next carried out immuno-EM analysis of mouse primary neuronal cultures, as these preparations are largely devoid of non-neuronal cell types and can provide higher-resolution analysis 20, 21 . We did not observe any immunogold label in samples treated with secondary gold-conjugated antibodies alone (Supplementary Fig. 4a ). When we used antibodies to proteasome β2 and β5 subunits in mature cultured neurons, we observed ~40% of the immunogold signal at neuronal PMs ( Fig. 2a and Supplementary Fig. 4b ). Of those particles observed at neuronal PMs, 43% ± 2% overlaid PMs, 38% ± 1.7% were located at the intracellular face, and 19% ± 2.4% were at the extracellular face ( Fig. 2a ; mean ± s.e.m.). When we used similar immuno-EM approaches on cultured non-neuronal HEK293 cells, we did not observe PM localization of proteasomes; instead, particles localized to the cytoplasm (Supplementary Fig. 4c ). Because the conjugation of a primary antibody to a gold-particle-tagged secondary antibody can result in the gold particle being localized up to ~20 nm from the target antigen, we quantified the fine localization of gold particles near neuronal PMs and plotted each particle's distance from the PM. This was a linear measurement taken from the center of the PM to the centroid of the gold particle. A majority of particles overlaid the PM, with the particle density diminishing as a function of distance from the membrane (Fig. 2b) . Thus, the signal observed at PMs corresponds to a unique pool of membrane-localized proteasome subunits, rather than intracellular proteasome subunits. Because core proteasome subunits are not known to be present in the cell separate from the macromolecular proteasome complex, these data probably reflect the membrane localization of intact proteasomes 1 .
Neuronal membrane proteasomes are exposed to the extracellular space Immuno-EM analysis of samples stained with a previously validated antibody to the cytoplasmic domain of the voltage-gated (a-f) Immunoblots of neuronal lysates (left) or hippocampal slice preparations (right) probed with antibodies to core catalytic β2 (a,b), β5 (c,d), and α2 (e) proteasomal subunits and to 19S cap proteasome subunit Rpt5 (f); representative images from immunogold labeling with 12-nm gold particles. White boxes in the images on the left outline the region shown at higher magnification on the right. Arrows mark locations of immunogold label in the cytosol (white) or membrane (black). We analyzed >20 hippocampal slices per mouse from two 3-month-old mice. The bar graphs show the quantification of gold particles from cytosol (Cyto) and membrane (Mem) relative to the total number of particles counted. The numbers of micrographs examined to get at least 300 gold particles were 49 (a), 47 (b), 43 (c), 54 (d), 54 (e), and 92 (f). Data are presented as mean and s.e.m. of n = 10 groups of micrographs. Source data are available online. a r t i c l e s potassium channel Kv1.3 showed only cytosolic labeling and labeling on the intracellular face of the PM, as previously described 22 ( Supplementary Fig. 5a ). Our immuno-EM analysis showed 20S proteasome staining on the extracellular face of the PM, which raised the possibility that proteasomes may be exposed to the extracellular space (Figs. 1a-e and 2a, and Supplementary Figs. 3a-c and 4b). We decided to use three additional approaches to substantiate these findings: one to specifically detect proteasome subunits (antibody feeding), and two unbiased approaches to detect surface-exposed proteins (surface biotinylation and protease protection) ( Fig. 2c) . First, we used antibody feeding with live neuronal cultures 23, 24 . We did not observe any staining when we used secondary controls alone ( Supplementary Fig. 5b ). When we fed a primary antibody to an N-terminal extracellular epitope of the GluR1 ionotropic receptor (N-GluR1), we observed punctal staining as previously reported 25 . We did not observe staining when we fed an antibody to the intracellular protein MAP2 ( Fig. 2d) . When we used the antibody to the proteasome β5 subunit, we observed punctal localization that was largely eliminated by pretreatment of the antibody with the β5 blocking peptide ( Fig. 2d) .
To biochemically determine whether proteasomes were surface exposed, we applied previously described surface biotinylation/ purification approaches 26, 27 followed by immunoblotting with antibodies to actin, GluR1, Rpt5, and 20S proteasome subunits. As expected, in our streptavidin pulldown samples from surfacebiotinylated neurons, we did not detect cytosolic actin and did detect GluR1 ( Fig. 2e) . Consistent with 20S proteasomes being surface exposed, we detected core 20S proteasome subunits in our streptavidin pulldown but did not detect significant pulldown of Rpt5 ( Fig. 2e) . We took several measurements to ensure that our results were not due to poor cell health or enhanced cell permeability ( Supplementary Fig. 5c,d) .
As an orthogonal method for the identification of surface-exposed proteins, we used a protease protection assay that relies on the proteolysis of extracellularly exposed epitopes of proteins after the treatment of live cells with an extracellular protease 28, 29 . We treated cultured cortical neurons with proteinase K (PK) for varying times and then fractionated the neurons into cytosolic and membrane fractions. Immunoblotting showed that proteasomes fractionated to the membrane, similar to N-GluR1, and were susceptible to proteolysis by extracellular PK (Fig. 2f) . In contrast, proteasomes from the cytosolic fraction, similar to tubulin, were protected from protease cleavage 30 ( Fig. 2f) . Because PK, when added to live cells, degrades proteins exposed to the extracellular space, we interpreted this observation as meaning that proteasomes were surface exposed and that the majority of proteasomes in our membrane preparations were from PMs, and not from other membrane organelles. We corroborated this by using concanavalin A (ConA), a lectin-binding protein that has been used to enrich PMs 31 (Supplementary Fig. 5e ). Taken together, these data support the existence of a surface-exposed proteasome complex at the neuronal PM. For convenience, we hereinafter refer to the proteasome localized to the neuronal PM as the neuronal membrane proteasome (NMP).
NMPs are tightly associated with PMs
We wanted to further enhance our biochemical understanding of how proteasomes, as largely hydrophilic complexes, could be localized to the hydrophobic PM. We isolated neuronal membranes and sequentially extracted them with increasing concentrations of digitonin to pull out increasingly hydrophobic proteins. We then prepared samples for western blotting (Fig. 3a) . Quantification of the immunoblots showed that a substantial percentage of αand β-subunits cofractionated with cytosolic proteins (tubulin) and hydrophobic membrane proteins (GluR1). These data are consistent with the fractionation of proteasomes in two different modes, one cytosolic and one membrane-bound, and thus provide additional evidence for a unique pool of membrane-localized proteasomes as opposed to cytosolic proteasomes ( Fig. 3a) . To determine whether NMPs are tightly or peripherally associated with plasma membranes, we used sodium carbonate extraction. We separated neuronal cultures into cytosolic, peripherally associated (carbonate-soluble) and tightly associated (carbonate-insoluble) membrane-protein fractions 29 . We used calregulin 32 as a marker of peripherally associated membrane proteins, and GluR1 as a marker of tightly associated membrane proteins. Immunoblotting of these fractions showed that core 20S proteasome components were tightly associated (carbonate-insoluble), whereas Rpt5 was peripherally associated (carbonate-soluble) ( Fig. 3b) .
We considered that there were two primary ways for this to be possible: (1) the proteasome itself could be hydrophobic in some way, or (2) the proteasome could be tightly associating with integral membrane proteins. To determine which of these possibilities was more likely, we performed Triton X-114 (TX114) phase partitioning of cultured neurons to separate hydrophilic from hydrophobic proteins 33 . Immunoblotting of the TX114-rich and TX114-free fractions showed . Arrows indicate cytosol (white) or membrane (red, cytosolic face; yellow, overlaying; green, extracellular face). We prepared >20 slices from multiple punches from single culture and examined 84 images to count a total of 523 gold particles. The bar graphs show quantification of gold particles from cytosol (Cyto) and membrane (Mem) (top) and from the cytosolic face of the membrane, the intramembrane face (overlaying), or the extracellular face of membrane (bottom). Data are mean and s.e.m. of n = 17 groups of micrographs. (b) Quantification of a subset of gold particles near membranes, shown in a. Each tick mark represents a distance of 2 nm; the PM is at the center. We examined approximately 84 micrographs to get 223 particles. Each black dot represents a single gold particle; the totals in each group are shown at the top. (c) Three different approaches to determine whether proteasomes are surface exposed. (d) Top: antibody feeding. Live primary mouse DIV14 cortical neuronal cultures were incubated with antibodies to MAP2, the N terminus of GluR1 (GluR1), or β5 proteasome subunits. Representative images are shown; scale bars, 10 µM. Bottom: staining with β5 antibody preincubated with the blocking peptide. The bar graph shows the percent overlap (mean and s.e.m.) from 30 neurons from two experiments with independent neuronal cultures. *P < 0.01 (two-tailed Student's t test) for comparison of β5 antibody to β5 antibody preincubated with blocking peptide. (e) Top: proteins from surface-biotinylated DIV14 cortical neurons were precipitated on streptavidin affinity beads and immunoblotted. Representative immunoblots of input lysates (~3.5% of total) and streptavidin pulldown of lysates (Strep; ~11% of total) are shown. Bottom: quantification of streptavidin signal normalized to input signal, shown as mean and s.e.m. of n = 4 experiments from independent neuronal cultures. *P < 0.01, one-way analysis of variance (ANOVA); GluR1 was compared to actin. (f) Top: PK was applied to DIV14 cultured cortical neurons for the indicated times. Cytosolic (Cyto) and membrane (Mem) fractions were immunoblotted. Bottom: quantification normalized to the zero time point for each antibody, shown as mean and s.e.m. of n = 3 experiments from independent neuronal cultures. *P < 0.01 (two-tailed Student's t test) versus the respective t 0 value. Uncropped blots are shown in Supplementary Data Set 1. Source data are available online. a r t i c l e s that actin fractionated into the TX114-free phase, multipass transmembrane protein GluR1 fractionated into the TX114-rich phase, and EphB2, a single-pass transmembrane protein, fractionated into both phases ( Fig. 3c) . Proteasome subunits also fractionated into both phases, although only ~20-30% of proteasome subunits fractionated into the TX114-rich phase ( Fig. 3c) . Together, our immuno-EM, surface biotinylation, and membrane fractionation data showed that up to 40% of proteasome subunits were localized to the PM. We reasoned that the discrepancies among these analyses might be due to the fact that proteasomes were not sufficiently hydrophobic to exist in the PM without auxiliary membrane proteins.
Neuronal membrane proteasomes are largely 20S complexes with GPM6
To identify potential auxiliary membrane proteins associated with the NMP, we isolated proteasome complexes from neurons by two different affinity methods 34 . We incubated cytosolic and membraneextracted fractions from neuronal cultures with a 20S purification and 26S affinity-purification matrices isolated cytosolic proteasomes, but only the 20S purification matrix was able to purify proteasomes out of the membrane (Fig. 4a) , which suggested that this approach could be used to purify the NMP. Using the 20S purification matrix, we purified 20S proteasomes from the cytosol and membrane of neurons for in-depth mass spectrometry (MS) analysis. As expected, we identified all of the core 20S proteasome subunits in the purification from both membranes and cytosol ( Supplementary Table 1a ). Although a variety of regulatory cap proteins copurified with the cytosolic proteasome, we identified very few that copurified with the proteasome from membranes ( Supplementary Table 1a ). We validated these findings by immunoblot analysis (Supplementary Fig. 6a-c) .
We sought to identify auxiliary membrane proteins in our MS data sets that could mediate proteasome association with the PM. We postulated that such proteins would associate specifically with the NMP rather than the cytosolic proteasome, be highly expressed in the nervous system, and be transmembrane proteins ( Supplementary Table 1b ). With these criteria in mind, we focused our efforts on the neuronal membrane glycoprotein GPM6A, a known member of the proteolipid protein family of multipass transmembrane glycoproteins 35, 36 . To validate the MS data, we used HEK293 cells as a non-neuronal heterologous system that does not express the NMP ( Supplementary  Fig. 7a ). We immunoprecipitated lysates from HEK293 cells that had been previously transfected with expression plasmids encoding MYC/ Flag-tagged GPM6A and GPM6B (MYC/Flag-GPM6A/B) by using an antibody to Flag. Immunoblotting with antibodies to MYC and to 20S proteasome subunits showed that endogenous proteasome subunits from HEK293 cells coimmunoprecipitated with MYC/Flag-GPM6A/B (Fig. 4b) . Although we interpreted these data as meaning that proteasomes can associate with GPM6 proteins, as demonstrated by our MS data from neurons, we wanted to know whether the GPM6 proteins could induce the proteasome to become membrane bound and surface exposed. Using the surface biotinylation assay, we determined that the expression of GPM6A and GPM6B in HEK293 cells was sufficient to induce surface expression of the endogenous HEK293 proteasome at the PM (Fig. 4c) . We did not obtain the same results after overexpression of GFP, the single-pass transmembrane protein EphB2, or the multipass transmembrane protein channelrhodopsin 2 ( Fig. 4c) . We uniformly detected the PM protein transferrin, thus verifying equal pulldown efficiency ( Fig. 4c) . Additionally, overexpression of MYCtagged β5 proteasome subunit together with MYC/Flag-GPM6A/B led both MYC-β5 and the endogenous subunits to become surface exposed (Fig. 4c) . This phenocopied the phenomenon we observed in primary cultured neurons, and indicated that the GPM6A/B proteins are sufficient to expose proteasomes to the extracellular space. Our attempts to determine whether GPM6-family proteins are required for NMP expression were unsuccessful, as short hairpin RNA (shRNA)mediated knockdown of Gpm6a and/or Gpm6b in neuronal cultures induced cell death (data not shown), which suggests that GPM6 proteins may be essential for viability.
GPM6A and GPM6B are expressed primarily in the nervous system 37 . In fact, surface biotinylation assays in whole mouse tissues showed that NMP expression was restricted to neuronal tissues ( Fig. 4d) . We obtained similar results with human brain tissue (Supplementary Fig. 7b ). We thus asked whether NMP expression was regulated and changed during neuronal development. A surface biotinylation assay of slice preparations from mouse brain showed that NMP expression paralleled the in vivo expression patterns of GluR1, which functionally correlate with critical stages in neuronal development 26 (Fig. 4e) . When we carried out the a r t i c l e s same experiments with neuronal cultures, we observed that the NMP was expressed in neurons at 8 days in vitro (DIV8), but not before then ( Supplementary Fig. 7c,d) , in contrast to the relatively constant total proteasome expression.
NMPs degrade intracellular proteins into extracellular peptides
To test whether the NMP was catalytically active, we purified proteasomes from both the cytosol and neuronal PMs using a 20S purification matrix and incubated them with SUC-LLVY-AMC, a substrate that fluoresces upon proteasomal chymotrypsin-like cleavage 38 . The addition of a low concentration of SDS to the reaction relieves the gating mechanism of the 20S proteasome without denaturing the 20S or 26S proteasome holocomplex 4 . The addition of SDS greatly stimulated the catalytic activity of membrane proteasomes and had little effect on cytosolic proteasome activity ( Fig. 5a and Supplementary  Fig. 8a) , consistent with a large fraction of NMPs being 20S and catalytically active.
We explored the function of a surface-exposed catalytically active 20S proteasome in the neuronal PM. As the core 20S complex alone is ~11 × 15 nm, any orientation of the NMP at the neuronal PM, which is 6-10 nm across, would provide access to both the intracellular and the extracellular space. We hypothesized that in neurons, a catalytically active proteasome in such an orientation would be able to promote proteasome-dependent degradation of intracellular proteins and release products into the extracellular space. To test this hypothesis, we used 35 S-methionine/cysteine radiolabeling to trace the fate of newly synthesized intracellular proteins 39 (Fig. 5b) . After 10 min of radiolabel incorporation (Fig. 5c) , we washed away free isotope and collected media over a time course for liquid scintillation analysis. We observed a rapid release of radioactivity into the culture medium under baseline conditions (Fig. 5d) . Radioactive flux decreased significantly after the addition of the proteasome inhibitor MG-132, without any effect on radiolabeling efficiency (Fig. 5c,d) . The addition of ATPγS, a nonhydrolyzable ATP analog, (d) Surface-exposed proteasome expression is unique to nervous system tissues. Tissues used from P3 mice were surface biotinylated. Shown are representative immunoblots of input lysates (2% of total) and streptavidin pulldowns of lysates (4% of total). Ctx, cortex; Hip, hippocampus; Olf, olfactory bulb; Brn, hind brain; Ht, heart; Lg, lung; Kid, kidney; Lv, liver; Pnc, pancreas. (e) Representative western blots of input lysates (2.5% of total) and streptavidin pulldowns (7.5% of total) of biotinylated proteins after surface biotinylation of mouse cortex tissue dissected from mice of the indicated postnatal ages. Uncropped blots are shown in Supplementary Data Set 1. Source data are available online.
a r t i c l e s had no effect on the release of radioactive material (Fig. 5d) . This was consistent with the release of radioactivity being due to an uncapped 20S proteasome, which does not require ATP. To determine whether the released radiolabel was incorporated into protein peptides, we treated different fractions from the media with PK to break down peptidergic material into single amino acids and dipeptides. Of the released radioactive material at the 2-min collection time, 82% ± 5% (mean ± s.e.m.) consisted of PK-sensitive molecules that ranged between 500 and 3,000 Da in size (Fig. 5e) . We observed similar results at the 30-min collection time ( Supplementary  Fig. 8b) . As proteasome cleavage products are peptides between 500 and 3,000 Da in size, we conclude that a large fraction of the radiolabeled material in the media was composed of protein peptides derived from a proteasome 40 , and not individual amino acids or small molecules. To discriminate between cytosolic and membrane proteasomes in mediating the efflux of extracellular peptides, we took advantage of the temporal switch in NMP expression between DIV7 and DIV8-namely, both DIV7 and DIV8 neurons express cytosolic proteasomes, but only DIV8 neurons express the NMP (Supplementary Fig. 7c,d) . We observed proteasome-dependent release of radiolabeled peptides into the media at DIV8, but not at DIV7, which paralleled the temporal expression of the NMP (Fig. 5f) . Consistent with this being an NMP-mediated neuronal phenomenon, we did not observe proteasome-dependent release of radiolabeled peptides in heterologous HEK293 cells that did not express the NMP (Supplementary Fig. 8c ). Taken together, these a r t i c l e s data support our hypothesis that the NMP degrades intracellular proteins into extracellular peptides.
NMPs are required for the release of extracellular peptides, and modulate neuronal activity
To specifically determine the contribution of the NMP to the generation of these extracellular peptides, separate from that of the cytosolic proteasome, we identified a chemical tool that was selective to the NMP. We found that biotinylation of the nonreactive portion of epoxomicin, a highly potent and specific proteasome inhibitor, generates a cell-impermeable compound (biotin-epoxomicin) that maintains target specificity 41 . This compound covalently modifies the catalytic proteasome β-subunits, tagging them with biotin. We separated cultured neurons that had been acutely treated with biotin-epoxomicin into cytosolic and membrane fractions and then subjected them to immunoblotting with streptavidin-AF647. Biotin signal was observed only in membranes from neurons treated with biotin-epoxomicin, and at the appropriate molecular weight denoting the covalent modification of the membrane proteasome β-subunits (Fig. 6a) . Furthermore, immuno-EM analysis of neuronal cultures treated with biotin-epoxomicin showed 92% ± 5% (mean ± s.e.m.) of biotin at PMs ( Fig. 6b and Supplementary Fig. 9a ). Any cytosolic a r t i c l e s labeling was probably due to binding of endogenously biotinylated proteins by streptavidin-Au, as we detected low-abundance cytosolic labeling in cultures that were not treated with biotin-epoxomicin ( Supplementary Fig. 9a,b) . Because biotin was directly labeled with streptavidin-Au, this analysis reduced the distance between the gold particle and the target antigen compared with that obtained with conventional antibody-based immuno-EM approaches. These data show that NMPs overlay neuronal PMs and are exposed to the extracellular space, and they provide further evidence that the NMP is catalytically active, as epoxomicin requires proteasome activity to bind to and inhibit the catalytic subunits 42 . These data established biotinepoxomicin as a useful tool for studying the relevance of the NMP.
We sought to use this inhibitor to separate the role of the NMP from the role of the cytosolic proteasome in regulating extracellular peptide production. Acute application of biotin-epoxomicin to radiolabeled neurons inhibited the release of radioactive peptide into the extracellular space (Fig. 6c) . We then decided to use biotinepoxomicin to test our initial hypothesis that the NMP could mediate rapid neuronal signaling. To test whether the NMP was relevant to aspects of neuronal signaling, we measured changes in intracellular calcium levels, which can serve as a rapid readout for many types of neuronal signaling 43 . We carried out calcium imaging in GCaMP3transfected cultured neurons treated with perfusate containing the GABAergic receptor antagonist bicuculline, which, by relieving inhibition on neuronal circuits, induces regular firing of action potentials and calcium transients 43 . After 2 min of bicuculline stimulation, we switched the perfusate to a buffer that contained both bicuculline and 25 µM biotin-epoxomicin. Within 10-30 s of biotin-epoxomicin addition, we observed rapid and robust attenuation of the amplitude of bicuculline-induced calcium transients, similar to that observed after the acute addition of MG-132 ( Fig. 6d,e ). The addition of biotinepoxomicin induced substantial variability in the frequency of calcium transients: 47% of neurons displayed an increase in frequency, whereas the same treatment induced potent abrogation of bicuculline-induced calcium signals in 31% of neurons (Fig. 6f) . These data suggest that an endogenous function of the NMP is to modulate the strength and speed of activity-dependent neuronal signaling through its proteolytic activity, possibly through the actions of the resulting extracellular peptides.
NMP-derived peptides are sufficient to induce neuronal signaling
To systematically test the effects of proteasome-directed peptide signaling, we purified and then perfused peptides onto GCaMP3-encoding a r t i c l e s neurons under various conditions. We ensured that the neurons were healthy at the end of every experiment by stimulating them with 55 mM KCl, which consistently induced strong calcium signaling. We purified and lyophilized the proteasome-directed peptides after extensive dialysis into ammonium bicarbonate to remove small molecules and neurotransmitters. We resuspended the lyophilizate in calcium imaging buffer. We determined that the peptide concentration in the lyophilizate was ~50 ng/ml, and we added peptides back at that concentration. Alone, purified peptides induced a robust degree of calcium signaling in naive neurons (Fig. 7a) . This peptideinduced stimulation was eliminated when the peptide purification was done in the presence of PK (Fig. 7b) . These data suggest that the observed calcium-signaling effects were due to the actions of extracellular protein peptides, and not small molecules or excitatory amino acids. Moreover, media collected in the presence of MG-132 did not possess the capacity to stimulate naive neuronal cultures (Fig. 7c) , which indicates that the relevant bioactive peptides were derived from the proteasome. In similar experiments, the addition of random peptides to GCaMP3-encoding neurons did not stimulate naive neuronal cultures (Supplementary Fig. 10 ). We then determined that these peptides were inducing calcium flux from the outside of the cell in, rather than promoting release from intracellular calcium stores. Addition of the cell-impermeable calcium chelator BAPTA to the perfusate abrogated the peptide-induced calcium signal (Fig. 7d) , whereas depletion of endoplasmic reticulum calcium stores by thapsigargin did not reduce the maximum amplitude of the peptide-induced calcium signal (Fig. 7e) .
To identify which channels were relevant to peptide-induced calcium activity, we used different ion channel inhibitors to pharmacologically identify relevant pathways. Blocking fast voltage-gated sodium channels with tetrodotoxin did not block the peptide-induced calcium signal, which revealed that the influx of calcium was probably not due to action-potential-induced signaling, and more likely was directly due to effects on calcium channels (Fig. 7f) . The blockade of L-type calcium-channel-dependent influx by nifedipine also did not modulate the peptide-induced calcium signal (Fig. 7g) . However, the inhibition of N-methyl-d-aspartate receptors (NMDARs) by 2-amino-5-phosphonopentanoic acid (APV) reduced the maximum amplitude of the peptide-induced calcium influx (Fig. 7h) . Together, these data suggest that the peptides derived from the NMP can modulate neuronal activity, at least in part by driving calcium influx through NMDARs (Fig. 7i) .
DISCUSSION
We report here that a 20S proteasome complex is tightly associated with the neuronal PM and exposed to the extracellular space. In this arrangement, the NMP can degrade intracellular proteins into bioactive extracellular peptides that induce calcium signaling through NMDA receptors. On the basis of these data, we propose a model in which a 20S proteasome complex is coupled to the PM by GPM6 glycoproteins, and the extracellular peptides generated are the means by which the NMP acutely regulates neuronal function.
The identification of GPM6-family glycoproteins as proteins that interact with proteasomes and are sufficient to induce their localization at the PM provides insight into how proteasomes, as hydrophilic protein complexes, can interact so closely with the hydrophobic PM. However, we noticed that the magnitude of GPM6-induced membrane proteasome expression in heterologous cells did not match the magnitude of endogenous membrane proteasome expression in neurons. This suggests that there may be other proteins that mediate the interaction of the NMP with the membrane.
We postulate that the GPM6 glycoproteins may form a protein pore, perhaps through oligomeric interactions, which have been proposed previously 35, 44 . Pore-forming membrane proteins could provide proteasomes with a hydrophilic binding surface within the hydrophobic PM, thereby allowing the proteasome to gain access to the extracellular space. We propose a few models for how GPM6 proteins, or other membrane tethers, may localize the proteasome to the PM (Fig. 8) . In each case, we posit that (1) proteasomes must be located at the PM, (2) proteasomes must be bound in some fashion to auxiliary membrane proteins such as GPM6, and (3) proteasomes must be able to degrade proteins from the intracellular to the extracellular space.
Model 1: cytoplasmic docking. A proteasome located at the PM is docked on or tethered to auxiliary membrane proteins on the cytoplasmic side of the membrane. Degraded proteins are shed through a peptide pore formed by the auxiliary proteins.
Model 2: extracellular docking. A proteasome located at the PM is docked on or tethered to auxiliary membrane proteins on the extracellular side of the membrane. Proteins are delivered through a protein pore formed by the auxiliary proteins.
Model 3: intramembrane docking. A proteasome located at the PM is tethered or anchored to auxiliary membrane proteins within the lipid bilayer.
The cell-biological conundrum of how a proteasome can interact with the PM may be the most significant question to address in order to gain a deeper understanding of NMP function. Because antibody feeding and protease protection require that large molecules gain access to the proteasome, we posit that model 1 is less likely, and that either model 2 or model 3 will prevail. Although we find these models most consistent with our data, we certainly do not preclude other potential models. Ultimately, the nature of this seemingly transmembrane complex can be validated only by a structural approach. The data we obtained in our search for NMP interaction partners, in which we also aimed to determine whether the NMP was capped by known factors, probably preclude the presence of the canonical 19S proteasome cap or regulatory caps such as 11S and PA200 (refs. 4,45,46) . Although our MS experiments identified a few 19S subunits that cofractionated with the NMP, we could not detect significant amounts of key 19S subunits Rpt5 or S2. We also made the intriguing observation that immunoproteasome subunit PSMB8 uniquely cofractionated with the NMP. Our finding that the NMP is probably a 20S core proteasome that lacks the 19S cap is significant for two primary reasons. First, although a few functions have been ascribed to 20S proteasomes, their function independent of the 19S cap largely remains a mystery, especially in the nervous system 46 . Second, important implications arise from the idea that 20S proteasomes primarily clear misfolded or unstructured proteins 4, 47, 48 . These end products of proteotoxic stress are hallmarks of many neurodegenerative disorders 46, 49 , a fact that places the NMP potentially at the heart of various disease states.
Unconventional secretion pathways have been implicated in the release of cellular protein cargos 50, 51 . Moreover, many groups have demonstrated that the inhibition of ubiquitin-dependent proteasome function affects synaptic signaling and transmission. Our data support a role for a specialized NMP that mediates neuronal function by 'inside-out' signaling through the production of extracellular a r t i c l e s proteasome-derived peptides. Although it remains a possibility, we have not detected any role for secretion pathways or ubiquitin in the release of these peptides (data not shown).
Proteasome-derived peptides, when purified, rapidly and robustly stimulate neurons. Pharmacological dissection of the downstream pathways of peptide signaling revealed that NMP-derived peptides act in part by modulating NMDARs. The signaling through NMDARs makes up only ~50% of the total activity of the peptides. There are other possible mechanisms: peptides could (1) interact with major histocompatibility immune complexes, which have recently been shown to have key roles in developmental and experience-dependent mechanisms in the nervous system 52, 53 ; (2) modulate metabotropic ion channels, thereby altering calcium-mediated signaling; and/or (3) signal to neuronal or non-neuronal cells such as glial cells through currently unidentified receptors.
It is well established that NMDARs are critical for neuronal-activitydependent signaling relevant to learning and memory [54] [55] [56] . Given that cytosolic proteasomes have been shown to be regulated by neuronal activity, it will be intriguing to investigate whether the NMP and the resulting extracellular peptides are also modulated by changes in neuronal activity. It is also unclear how this signaling is specified within the brain, but we postulate that it depends on how the NMP recognizes and targets proteins for degradation. Therefore, it will be critical to identify not only the sequences of the peptides, but also the substrates from which they are derived. These insights into substrate identity and targeting will reveal how the NMP functions, and may link proteostatic failure under pathological conditions to NMP dysfunction.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. on the experiment, and each sample was labeled using sulfo-NHS-LC-biotin (Thermo Fisher). Cultured cells were washed in PBS (Gibco), pH 8.0, with 1 mM CaCl 2 and 2 mM MgCl 2 (PBSCM) and treated with 1 mg/mL sulfo-NHS-LCbiotin dissolved in PBSCM for 20 min at 4 °C before the reaction was quenched for 10 min in 50 mM glycine in PBSCM. Intact tissue was quickly and manually chopped after only 10 min of biotinylation at 4 °C in 0.5 mg/mL sulfo-NHS-LC-biotin before quenching of the reaction. Whole mouse tissues and cultured neurons were collected and homogenized in RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM EDTA, complete protease inhibitor cocktail tablet (Roche), 1 mM β-glycerophosphate). Where indicated, the salt concentration in our RIPA lysis buffer was increased up to 300 mM NaCl. Primary human central nervous system tissue, from subjects at gestational weeks 19-21, was obtained under surgical written consent according to protocols approved by the Johns Hopkins Institutional Review Board, based on its designation as biological waste. The tissue was mechanically chopped at 4 °C and then immediately processed for surface biotinylation. For streptavidin pulldown experiments, lysed cells were incubated with high-capacity streptavidin agarose beads (Thermo Fisher) overnight and then washed thrice with RIPA buffer before elution in SDS sample buffer. Western blotting was done according to conventional approaches. Gels were run either on 4-15% SDS-PAGE gradient gels (Bio-Rad) or on 10% gels made in the laboratory. Proteins were transferred to nitrocellulose membranes at 100 V for 1.5 h in 20% methanol containing transfer buffer. All antibodies were made up in 5% BSA in 0.1% TBST. Western blots were incubated with appropriate secondary antibodies conjugated to horseradish peroxidase, extensively washed, and incubated with ECL. Images were exposed on film, and were scanned in and quantified with ImageJ by standard densitometry analysis.
Cellular fractionation and integral membrane determination.
For cellular fractionation experiments to determine the membrane attachment of the proteasome, cultured neurons were lysed in either a sucrose buffer (0.32 M sucrose, 5 mM HEPES, 0.1 mM EDTA, 0.25 mM DTT) or hypotonic lysis buffer (5 mM HEPES, 2 mM ATP, 1 mM MgCl 2 ) and collected. Nuclei were pelleted at 800 r.p.m. for 5 min, and the supernatant containing membranes was pelleted at 55,000 r.p.m. for 1 h. Pelleted membranes were washed twice by homogenization in lysis buffer and re-pelleted. After two washes, membranes were processed for appropriate application. Supernatants containing the cytosolic extracts were concentrated down to the same volume that membranes were eventually resuspended in. Membrane association was determined by classic methods of sodium carbonate extraction. Briefly, purified neuronal membranes were resuspended in 50 mM sodium carbonate, pH 11, and incubated for 10 min at 4 °C to strip away membrane-associated proteins. Membranes, along with tightly associated membrane proteins, were pelleted at 55,000 r.p.m. for 1 h. Membrane incubation with sodium carbonate at high pH is thought to strip peripherally associated proteins from the membranes, leaving only tightly associated and integral membrane proteins bound to the membranes. Samples were subsequently prepared for SDS-PAGE analysis. For digitonin fractionation, samples were lysed in sucrose buffer. Once the supernatant (cytosolic fraction) was set aside, the pellet was washed twice with sucrose buffer and then resuspended in sucrose buffer with different concentrations of digitonin. After a 30-min incubation in the buffer, samples were spun down at 55,000 r.p.m. for 1 h. This process was repeated for all concentrations of detergent used . For Figure 3a , on the basis of our fractionation protocol, we calculated that the input was about 60% cytosol and 40% membrane. We collected only the non-nuclei, non-mitochondria membrane (i.e., 20% of remaining membranes). For the western blots shown in Figure 3a , we used 10 µl of input and ~3×-purified cytosol and ~5×-purified membrane. By combining the data from the cytosol and membrane fractions and considering the error in our experimental approach, we can surmise that the proteasome signal from our input probably came from both the cytosol and a larger fraction from the membrane preparations. Because our input includes all the cellular material, and because the fractionation removed the nuclei and mitochondria, we believe that a very small amount, if any, of the proteasome signal in our input can account for that coming from these organelles.
TX114 phase extraction. We adapted our protocol from ref. 33 . Briefly, primary neuronal cultures were treated with 1% precondensed TX114. Samples were dounce-homogenized, spun at 4 °C, and incubated at 30 °C. Samples were centrifuged for 3 min at room temperature. Supernatant was retained as the TX114-free fraction, and the resulting pellet was kept as the TX114-rich fraction. This approach relies upon a temperature-dependent shift of the critical micellar concentration of TX114, and provides an approximate determination of the hydrophobicity of proteins.
Concanavalin A plasma membrane isolation. We adapted our protocol from ref. 31 . Briefly, 0.25 mg of biotinylated ConA was first coupled to 1 mL of streptavidin-coated agarose beads. Nuclei were pelleted from hypotonically lysed DIV16 cultured cortical neurons, as described above, and the supernatant containing PMs and cytosol was applied to 150 µl of ConA-coupled beads. After thorough washing in lysis buffer containing 0.025% Nonidet-P40, samples were prepared for SDS-PAGE and western blotting analysis.
DNA constructs. The full-length mouse tagged GPM6A, tagged GPM6B, and tagged β5 constructs were acquired from Origene. We verified and tested all vectors obtained from commercial sources for the appropriate expression of the inserts by using primary antibodies or epitope-tag antibodies to the expressed proteins. We keep stocks of each validated plasmid, and we periodically sequence these plasmids to confirm their authenticity. All plasmids used in this study were amplified and purified with standard kits from commercial vendors.
shRNA knockdown. We obtained four unique shRNA constructs against each of Gpm6a, Gpm6b, and Plp1 from Origene. These were validated HuSH 29-mer shRNA constructs expressing GFP. Each construct was transfected into neurons via previously described and standard protocols. Each construct was transfected at 100 ng and 500 ng per well. In addition, the constructs were cotransfected in combination to knock down either two or all three genes.
Human subjects. Fetal brain tissue was obtained at Johns Hopkins University. Primary cultures of fetal cortical tissues were prepared. The use of fetal brain tissue was approved by the Johns Hopkins University institutional review board. Informed consent was obtained from all subjects. The authors did not have access to any identifying personal information.
Coimmunoprecipitation. Transfected HEK293 cells were collected and homogenized in IP buffer (1% NP-40, 2 mM MgCl 2 , 300 mM NaCl, 2 mM CaCl 2 , 50 mM HEPES, 10% glycerol). For immunoprecipitation, lysates were incubated with Flag-M2 agarose beads (Sigma-Aldrich). Precipitated samples were washed and prepared for SDS-PAGE and immunoblotting.
Proteasome purification, and assessment of catalytic activity. For proteasome purification, cells were treated and then immediately put on ice before purifications were performed as previously described 45 . Briefly, proteasomes were purified out of neuronal cytosol and detergent-extracted neuronal PMs using the 20S proteasome purification kit (Enzo Life Sciences) or the 26S proteasome purification kit (UBPBio). The first method relies on proteasome immunoprecipitation with antibodies to proteasome β5 subunit covalently coupled to agarose beads (20S purification matrix). It is important to note that this purification scheme can purify any 20S-containing proteasome complex. As an alternative, we used a previously described affinity-purification method that utilizes GST-Ubl binding to the 19S cap and subsequent pulldown on glutathione-coupled Sepharose (26S purification matrix). This method enriches for proteasomes that are capped by the 19S complex. For western blotting, samples were denatured at 65 °C for 5 min in SDS sample buffer, resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted. For catalytic activity assays, one-sixth of the bead volume after proteasome purification was resuspended in activity assay buffer (20 mM Tris-HCl, pH 8.0, 5 mM ATP, 5 mM MgCl 2 , 1 mM DTT). 26S proteasomal activity was assessed by the addition of 10 µM SUC-LLVY-AMC (Enzo Life Sciences). The contribution of 20S proteasomal activity was assessed by comparison of 26S proteasome activity to total proteasome activity (26S + 20S), as measured by the activity of samples containing SDS at a final concentration of 0.05%.
Cell-culture radiolabeling. Cortical neurons were cultured for 12 days in vitro. Radioactive labeling was done in Neurobasal growth media with B-27 supplement and without methionine or cysteine (special-ordered from Life Technologies). 35 S-methionine/cysteine (EasyTag; PerkinElmer) was incorporated at 55 mCi
